Ever popular e-cigarettes were marketed as being safer than traditional tobacco-filled cigarettes. With vape-related lung illnesses circulating in headlines, the FDA a issued to letter to JUUL Labs concerning their marketing violations.
JUUL failed to follow federal regulations when it had no scientific data to back its claims. The FDA determined that JUUL marketed its products without an FDA order in effect.
Acting FDA Commissioner Ned Sharpless, M.D, explains, "Regardless of where products like e-cigarettes fall on the continuum of tobacco product risk, the law is clear that, before marketing tobacco products for reduced risk, companies must demonstrate with scientific evidence that their specific product does in fact pose less risk or is less harmful. JUUL has ignored the law, and very concerningly, has made some of these statements in school to our nation’s youth.”